SCINAI IMMUNOTHERAPEUTICS LTD. Adjustments For Finance Income Cost
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Adjustments For Finance Income Cost of ILS 1.33 million for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceIncomeCost · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for finance income cost for the quarter ending 2022-06-30 was 1.33M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for finance income cost for the quarter ending 2021-12-31 was -1.34M ILS, a 430.22% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for finance income cost for the quarter ending 2021-09-30 was 1.80M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for finance income cost for the quarter ending 2021-06-30 was -520.00K ILS.
ILS
| Period end | Adjustments For Finance Income Cost 3 month | Adjustments For Finance Income Cost 6 month | Adjustments For Finance Income Cost 9 month | Adjustments For Finance Income Cost 12 month |
|---|---|---|---|---|
| 2022-06-30 | 1.33M ILS 6-K/A · filed 2022-08-29 | 2.11M ILS 6-K/A · filed 2022-08-29 | ||
| 2021-12-31 | -1.34M ILS derived: 6-K/A 12 month − 6-K/A 9 month · filed 2022-08-29 | 459.00K ILS derived: sum of 2 quarters · filed 2022-08-29 | -61.00K ILS derived: sum of 3 quarters · filed 2022-08-29 | 930.00K ILS 6-K/A · filed 2022-08-29 |
| 2021-09-30 | 1.80M ILS 6-K/A · filed 2021-12-27 | 1.28M ILS derived: sum of 2 quarters · filed 2022-08-29 | 2.27M ILS 6-K/A · filed 2021-12-27 | |
| 2021-06-30 | -520.00K ILS 6-K/A · filed 2022-08-29 | 471.00K ILS 6-K/A · filed 2022-08-29 | ||
| 2020-12-31 | 407.00K ILS derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | 122.00K ILS derived: sum of 2 quarters · filed 2022-03-28 | -21.48M ILS derived: sum of 3 quarters · filed 2022-03-28 | -12.94M ILS 20-F · filed 2022-03-28 |
| 2020-09-30 | -285.00K ILS 6-K/A · filed 2021-12-27 | -21.89M ILS derived: sum of 2 quarters · filed 2021-12-27 | -13.35M ILS 6-K/A · filed 2021-12-27 | |
| 2020-06-30 | -21.60M ILS 6-K · filed 2020-10-02 | -13.06M ILS 6-K · filed 2020-10-02 | ||
| 2019-12-31 | -9.32M ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | -12.52M ILS derived: sum of 2 quarters · filed 2022-03-28 | -18.14M ILS derived: sum of 3 quarters · filed 2022-03-28 | -15.90M ILS 20-F · filed 2022-03-28 |
| 2019-09-30 | -3.21M ILS 6-K · filed 2021-01-28 | -8.83M ILS derived: sum of 2 quarters · filed 2021-01-28 | -6.59M ILS 6-K · filed 2021-01-28 | |
| 2019-06-30 | -5.62M ILS 6-K · filed 2020-10-02 | -3.38M ILS 6-K · filed 2020-10-02 | ||
| 2018-12-31 | 2.05M ILS 20-F · filed 2021-05-13 | |||
| 2017-12-31 | -10.89M ILS 20-F · filed 2020-06-12 |
USD
| Period end | Adjustments For Finance Income Cost 3 month | Adjustments For Finance Income Cost 6 month | Adjustments For Finance Income Cost 9 month | Adjustments For Finance Income Cost 12 month |
|---|---|---|---|---|
| 2022-06-30 | $602.00K 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | -$405.00K derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | $299.00K 20-F · filed 2022-03-28 | ||
| 2021-09-30 | $704.00K 6-K/A · filed 2021-12-27 | |||
| 2020-12-31 | -$4.03M 20-F · filed 2021-05-13 |